Stay updated on Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial

Sign up to get notified when there's something new on the Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision: v3.6.4 is now shown in the page footer, replacing the previous v3.6.3. This reflects a minor version update to the site's interface rather than changes to the study data.
    Difference
    0.0%
    Check dated 2026-07-25T08:22:53.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The website now displays Revision: v3.6.3, replacing the previous Revision: v3.6.2, indicating an update to the page's revision identifier rather than to study data or content.
    Difference
    0.0%
    Check dated 2026-07-03T21:48:14.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    An updated software build identifier (v3.6.2) is now displayed on the page, replacing the previous v3.6.0. This appears to be routine page maintenance and does not modify the study information or visible content.
    Difference
    0.0%
    Check dated 2026-06-26T19:52:51.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Recruitment status is updated to No longer looking for participants, reflecting that participant enrollment has ended. The page also adds new user-facing sections (How to Read a Study Record, Common Questions, How to Join a Study), reformats the Intervention/Treatment heading, and lists Revision: v3.6.0 as the current version.
    Difference
    0.3%
    Check dated 2026-06-12T14:50:32.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The page's revision label was updated to v3.5.5, representing a minor version update to the page. This does not modify the study details or visible content.
    Difference
    0.0%
    Check dated 2026-06-05T10:54:54.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    Lakefront Biotherapeutics NV has been added to the Collaborators and Investigators section, and Galapagos NV has been removed. This reflects changes in collaboration and may affect attribution and the points of contact for the trial.
    Difference
    0.0%
    Check dated 2026-05-22T04:29:11.000Z thumbnail image

Stay in the know with updates to Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial page.